Precimed

Precimed (Suzhou) Medical Technology, also known as Precimed Biotech, is a clinical-stage biopharmaceutical company based in Suzhou, China, specializing in biomarker-driven drug discovery and precision medicine. The company utilizes its proprietary AIBI platform, which integrates multi-omics data and artificial intelligence, to identify novel therapeutic targets and develop corresponding companion diagnostics. Precimed's business model combines internal drug development with high-end diagnostic services and collaborations with major pharmaceutical companies to accelerate the delivery of personalized cancer treatments. Their pipeline primarily focuses on targeted oncology therapies designed to address specific genetic mutations in solid tumors.